Current product details, pricing, and terms can be confirmed by viewing the current GLPro offer (official GLPro page)
It may also aid blood sugar control in people with type 2 diabetes and may reduce symptoms of obsessive-compulsive disorder
Krolewski Research Division, Joslin Diabetes Center and Harvard Medical School Kevin Duffin Vice President, Aging Research, Eli Lilly Jonathan Wilson Senior Director, Eli Lilly and Company Pavo Imre Senior Medical Director, Eli Lilly & Co, Vienna Fergus Fleming Co-founder, Executive Director and CTO, RenalytixAI Anna Nowak-Szwed, Eiichiro Satake, and Sok Cin Tye Joslin Diabetes Center / Harvard Medical School researchers advancing translational proteomics and kidney disease biomarker research #cardiometabolic #immunology #pathology #Proteomics #KidneyDisease #Nephrology #Diabetes #Biomarkers #GLP1 #Tirzepatide #Olink #PrecisionMedicine #TranslationalResearch #EliLilly To view or add a comment, sign in 88% of patients held steady or improved in Phase 2
All groups showed reductions in fasting blood glucose, body weight, BMI, waist circumference, and lipid parameters